Natural killer cell function predicts severe infection in kidney transplant recipients.

Cytomegalovirus (CMV) clinical research/practice immunosuppression/immune modulation infection and infectious agents infection and infectious agents - bacterial infection and infectious agents - viral: infectious disease kidney (allograft) function/dysfunction kidney transplantation/nephrology natural killer (NK) cells/NK receptors translational research/science

Journal

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
ISSN: 1600-6143
Titre abrégé: Am J Transplant
Pays: United States
ID NLM: 100968638

Informations de publication

Date de publication:
01 2019
Historique:
received: 22 11 2017
revised: 16 04 2018
accepted: 20 04 2018
pubmed: 1 5 2018
medline: 17 4 2020
entrez: 1 5 2018
Statut: ppublish

Résumé

The aim of this study was to determine if natural killer cell number (CD3

Identifiants

pubmed: 29708649
doi: 10.1111/ajt.14900
pii: S1600-6135(22)08908-0
doi:

Substances chimiques

Immunosuppressive Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

166-177

Informations de copyright

© 2018 The American Society of Transplantation and the American Society of Transplant Surgeons.

Auteurs

Claire Dendle (C)

Centre for Inflammatory Diseases, School of Clinical Sciences, Monash University, Clayton, Victoria, Australia.
Monash Infectious Diseases, Monash Health, Monash Medical Centre, Clayton, Victoria, Australia.

Poh-Yi Gan (PY)

Centre for Inflammatory Diseases, School of Clinical Sciences, Monash University, Clayton, Victoria, Australia.
Department of Immunology, Monash Pathology, Monash Health, Clayton, Victoria, Australia.

Kevan R Polkinghorne (KR)

Centre for Inflammatory Diseases, School of Clinical Sciences, Monash University, Clayton, Victoria, Australia.
Department of Nephrology, Monash Medical Centre, Clayton, Victoria, Australia.
Department of Epidemiology and Preventive Medicine, Monash University, Prahran, Victoria, Australia.

James Ngui (J)

Department of Immunology, Monash Pathology, Monash Health, Clayton, Victoria, Australia.

Rhonda L Stuart (RL)

Centre for Inflammatory Diseases, School of Clinical Sciences, Monash University, Clayton, Victoria, Australia.
Monash Infectious Diseases, Monash Health, Monash Medical Centre, Clayton, Victoria, Australia.

John Kanellis (J)

Centre for Inflammatory Diseases, School of Clinical Sciences, Monash University, Clayton, Victoria, Australia.
Department of Nephrology, Monash Medical Centre, Clayton, Victoria, Australia.

Karin Thursky (K)

National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Parkville, Victoria, Australia.

William R Mulley (WR)

Centre for Inflammatory Diseases, School of Clinical Sciences, Monash University, Clayton, Victoria, Australia.
Department of Nephrology, Monash Medical Centre, Clayton, Victoria, Australia.

Stephen Holdsworth (S)

Centre for Inflammatory Diseases, School of Clinical Sciences, Monash University, Clayton, Victoria, Australia.
Department of Immunology, Monash Pathology, Monash Health, Clayton, Victoria, Australia.
Department of Nephrology, Monash Medical Centre, Clayton, Victoria, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH